Jon Terrett

Jon Terrett is an accomplished professional in the biotech industry with extensive experience in research and development. Currently serving as CXO at Curie.Bio since November 2025, Jon focuses on assisting founders in the discovery and development of significant new medicines. Previously, Jon held the position of Head of Research at CRISPR Therapeutics from February 2017 to November 2025, and VP of Oncology at CytomX Therapeutics from March 2014 to February 2017. Prior roles include Chief Scientific Officer at Oxford Biotherapeutics, Director at Medarex, Director at Oxford Glycosciences, and Senior Investigator at Smithkline Beecham. Jon holds a PhD in Genetics from the University of Nottingham and a BSc in Genetics from The University of Sheffield.